{"GHMDC classification":["Preventative","Diagnosis"],"GHMDC health topic":["Maternal mortality"],"GHMDC manufacturer location":["Connecticut, united States"],"GHMDC scope":["Clinical trial"],"Page SDG":["SDG09 Industry innovation and infrastructure","SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Congo_Red_Dot_Test"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Preeclampsia is pregnancy-induced hypertension, or high blood pressure, and is associated with high protein levels in the urine. While high blood pressure is the most distinguished sign of the disease, it is also linked to damage in several organs such as the kidneys, liver, and endothelium. There is a critical need in the developing world for low-cost diagnostics for preeclampsia. Preeclampsia occurs in as many as 10% of pregnancies, usually in the second or third trimester, and after the 32nd week. It is particularly difficult to diagnose when preexisting disease such as hypertension is present."],"Page image":["File:Congoreddot.jpg"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Congo Red Dot Test"],"Page views":[216],"Page year":["Sunday, 01-Jan-12 00:00:00 UTC"],"Processing error":["Global Health Medical Device Compendium/Congo Red Dot Test# ERR002e8d28516d6fe77eb8de92db24adb8"],"Modification date":["Thursday, 10-Sep-26 14:21:35 UTC"]}